Suppr超能文献

纽约心脏协会心功能分级较高与左心室功能保留的心力衰竭患者死亡率及住院率增加相关。

Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function.

作者信息

Ahmed Ali, Aronow Wilbert S, Fleg Jerome L

机构信息

Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Alabama, Birmingham, AL, USA.

出版信息

Am Heart J. 2006 Feb;151(2):444-50. doi: 10.1016/j.ahj.2005.03.066.

Abstract

BACKGROUND

The association between higher New York Heart Association (NYHA) class and outcomes in patients with heart failure and preserved systolic function is not well known.

METHODS

We performed a retrospective follow-up study of 988 patients with heart failure with ejection fraction > 45% who participated in the DIG trial. Using Cox proportional hazard models, we estimated risks and all-cause mortality, heart failure mortality, all-cause hospitalization, and hospitalization due to worsening heart failure during a median follow-up of 38.5 months.

RESULTS

Patients had a median age of 68 years; 41.2% were women and 13.9%, nonwhites. Overall, 23.4% of patients died, and 19.9% were hospitalized because of worsening heart failure. Proportion of patients with NYHA classes I, II, III, and IV were 19.9%, 58.0%, 20.9%, and 1.2%, respectively, and 14.7%, 21.1%, 35.9%, and 58.3%, respectively, died of all causes (P < .001 for trend). Respective rates for heart failure-related hospitalizations were 14.2%, 17.1%, 32.5%, and 33.3% (P < .001 for trend). Compared with NYHA class I patients, adjusted hazard ratios (HRs) for all-cause mortality for class II, III, and IV patients were 1.54 (95% CI 1.02-2.32, P = .042), 2.56 (95% CI 1.64-24.01, P < .001), and 8.46 (95% CI 3.57-20.03, P < .001), respectively. Respective adjusted HRs (95% CI) for hospitalization due to heart failure for class II, III, and IV patients were 1.16 (0.76-1.77) (P = .502), 2.27 (1.45-3.56) (P < .001), and 3.71 (1.25-11.02) (P = 018). New York Heart Association classes II through IV were also associated with higher risk of all-cause hospitalization.

CONCLUSION

Higher NYHA classes were associated with poorer outcomes in patients with heart failure and preserved systolic function.

摘要

背景

纽约心脏协会(NYHA)心功能分级较高与射血分数保留的心力衰竭患者的预后之间的关联尚不明确。

方法

我们对参与DIG试验的988例射血分数>45%的心力衰竭患者进行了一项回顾性随访研究。使用Cox比例风险模型,我们在38.5个月的中位随访期内估计了全因死亡率、心力衰竭死亡率、全因住院率以及因心力衰竭恶化导致的住院率。

结果

患者的中位年龄为68岁;41.2%为女性,13.9%为非白人。总体而言,23.4%的患者死亡,19.9%的患者因心力衰竭恶化而住院。NYHA心功能I、II、III和IV级的患者比例分别为19.9%、58.0%、20.9%和1.2%,全因死亡的患者比例分别为14.7%、21.1%、35.9%和58.3%(趋势P<.001)。心力衰竭相关住院率分别为14.2%、17.1%、32.5%和33.3%(趋势P<.001)。与NYHA心功能I级患者相比,II、III和IV级患者全因死亡的校正风险比(HR)分别为1.54(95%CI 1.02 - 2.32,P =.042)、2.56(95%CI 1.64 - 24.01,P<.001)和8.46(95%CI 3.57 - 20.03,P<.001)。II、III和IV级患者因心力衰竭住院的相应校正HR(95%CI)分别为1.16(0.76 - 1.77)(P =.502), 2.27(1.45 - 3.56)(P<.001)和3.71(1.25 - 11.02)(P = 018)。NYHA心功能II至IV级也与全因住院风险较高相关。

结论

NYHA心功能分级较高与射血分数保留的心力衰竭患者较差的预后相关。

相似文献

2
A propensity matched study of New York Heart Association class and natural history end points in heart failure.
Am J Cardiol. 2007 Feb 15;99(4):549-53. doi: 10.1016/j.amjcard.2006.08.065. Epub 2006 Dec 28.
3
A propensity-matched study of the association of physical function and outcomes in geriatric heart failure.
Arch Gerontol Geriatr. 2008 Mar-Apr;46(2):161-72. doi: 10.1016/j.archger.2007.03.010. Epub 2007 May 25.
6
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Am J Med. 2020 Oct;133(10):1187-1194. doi: 10.1016/j.amjmed.2020.02.040. Epub 2020 Apr 6.
7
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
Eur J Heart Fail. 2013 May;15(5):551-9. doi: 10.1093/eurjhf/hft010. Epub 2013 Jan 25.

引用本文的文献

2
Value of Early Diagnosis and Treatment of Amyloidosis: A Pilot Study of Synovial Biopsy During Carpal Tunnel Release.
J Hand Surg Glob Online. 2025 Jul 23;7(5):100779. doi: 10.1016/j.jhsg.2025.100779. eCollection 2025 Sep.
5
Translation and Linguistic Validation of the Multidimensional Dyspnea Profile into Hindi in a Palliative Care Setting.
Indian J Palliat Care. 2024 Jul-Sep;30(3):252-259. doi: 10.25259/IJPC_46_2024. Epub 2024 Aug 23.
6
An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program.
CJC Open. 2024 Apr 10;6(8):989-1000. doi: 10.1016/j.cjco.2024.03.015. eCollection 2024 Aug.
8
Influencing and prognostic factors of end-stage hypertrophic cardiomyopathy.
ESC Heart Fail. 2024 Dec;11(6):4028-4037. doi: 10.1002/ehf2.15010. Epub 2024 Aug 2.
10
Insights into the Novel Cardiac Biomarker in Acute Heart Failure: Mybp-C.
Life (Basel). 2024 Apr 16;14(4):513. doi: 10.3390/life14040513.

本文引用的文献

2
Determination of vital status at the end of the DIG trial.
Control Clin Trials. 2003 Dec;24(6):726-30. doi: 10.1016/j.cct.2003.08.011.
3
Overview of the DIG trial.
Control Clin Trials. 2003 Dec;24(6 Suppl):269S-276S. doi: 10.1016/s0197-2456(03)00104-1.
4
Predicting mortality in patients with heart failure: a pragmatic approach.
Heart. 2003 Jun;89(6):605-9. doi: 10.1136/heart.89.6.605.
5
One-year mortality among unselected outpatients with heart failure.
Eur Heart J. 2002 Dec;23(23):1861-6. doi: 10.1053/euhj.2002.3282.
10
Defining diastolic heart failure: a call for standardized diagnostic criteria.
Circulation. 2000 May 2;101(17):2118-21. doi: 10.1161/01.cir.101.17.2118.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验